This article is cited by
-
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
Breast Cancer Research (2015)
-
Weekly paclitaxel—still preferred first-line taxane for mBC
Nature Reviews Clinical Oncology (2015)
-
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer
Breast Cancer Research and Treatment (2015)
-
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours
British Journal of Cancer (2014)
-
Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials
International Journal of Clinical Oncology (2013)